Home >

Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

A recent article in the ASCO Post has me thinking quite a bit about information and communication and the application of these concepts to...
It’s now time for my books of the year. Book lists are always personal: what I like isn’t what you’ll like or even what you would be willing to read. And what I enjoy doesn’t always make the list: I love mindless trash as much as the next person, but I would never inflict it on anyone. So no guilty...
Fact: If you are African American and you have cancer, you are more likely to die than if you are white. Fact: If you are uninsured and you have cancer, you are more likely to die than if you have medical insurance. We all know this but what are we doing about it?
In my presidential address at the Annual Meeting in June, I spoke about the perils and promise of the new genomic era, and our need as a profession and as a professional...
The essayist Christopher Hitchens is battling esophageal cancer, and like most fighting that battle, appears to be losing: he calls this “the year of living dyingly.” His writing on his encounters with the disease have been morbidly funny and heartfelt. I recently came across...
In my first blog post on this topic, I discussed the challenges of creating a culture of cure. It seems that the first hurdle we have to overcome before we talk further about...
Today, one-third of ASCO’s 30,000 members practice outside of the United States. Totaling more than 9,000 clinicians who collectively practice in more than 100 countries, ASCO’s international members represent extraordinary diversity of needs, challenges, and interests. Each and every one of these...
This week the FDA decided to withdraw bevacizumab's indication for treatment of metastatic breast cancer. The earlier indication had been approved under FDA's accelerated approval process wherein final approval was conditional on the generation of confirmatory evidence based on clinical trials.
The Institute of Medicine is the branch of the National Academy of Sciences that serves, in the words of its own website, as “an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to...
After the ASCO Integrated Media and Technology Committee meeting I was delayed at Reagan National Airport with poor Wi-Fi access. I resorted to reading a physical (yes, paper!) journal (...
I just finished reading George’s recent post on Evelyn Lauder, who recently passed away from ovarian cancer, and am still stirred by the passing of Patrick Swayze from pancreatic cancer and Elizabeth Edwards from...
My good friend Cliff Hudis has sent me a report from the New York Times announcing the passing of Evelyn Lauder, at the age of 75, from complications...
Let me start by mentioning 2 things I missed earlier about Day 1 of the ASCO HIT/EHRs Symposium.  In the session on Usability, Karen Bell, Chair of CCHIT, mentioned 3 areas where EHRs may impact malpractice risk; Communications, Documentation and Medical Errors. Each of these has the potential to...
The ABC1 conference has been going on in Lisbon, Portugal, for the past three days. ABC stands for Advanced Breast Cancer, and the conference has been a mix of didactic lectures (on all things metastatic) and guideline development. It’s the...
The November 3rd edition of the NEJM features a Perspective article on drug shortages by Mandy Gatesman and Thomas J Smith (NEJM 365:18 page 163) that address many of the causative issues that underlie this growing national problem.  
Today was day 1 of the ASCO HIT/EHR Symposium, which covered a wide range of the ever changing HIT landscape.  Paul Tang, Vice Chair of the ONC HIT Policy Committee, and Chuck Friedman, former Chief Scientific Officer of ONC, now Director of Health Informatics at the U. Michigan School of Public...
I was recently asked to comment on a study that sought to address the risk of ovarian cancer in women who undergo in vitro...

Pages


Advertisement